ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported a loss of $3.9 million in its fourth quarter.
The Alachua, Florida-based company said it had a loss of 9 cents per share. Losses, adjusted for stock option expense, were 6 cents per share.
The regenerative medicine company posted revenue of $42.9 million in the period.
For the year, the company reported that its loss narrowed to $21.7 million, or 51 cents per share. Revenue was reported as $159 million.
AxoGen expects full-year revenue in the range of $177 million to $181 million.
AxoGen shares have climbed 55% since the beginning of the year. The stock has increased 29% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN